Clinical Trials

Clinical trials are essential to ensure new drugs provide patients with safe and effective treatments.

Individuals who participate in a clinical trial make a crucial contribution to the discovery of new, more effective medicines, thereby improving the health and wellbeing of patients in the future. Participation in clinical trials is entirely voluntary. While clinical trials are typically recommended to patients by their treating physician, it is essential for individuals to be aware of potential opportunities to receive a life-changing drug as well as to contribute to improvements in the scientific understanding of their disease.

The results from clinical trials are submitted to independent regulatory agencies such as the US or China Food and Drug Administration’s (FDA or CFDA), who scrutinize the data to ensure all approved new medicines are safe and effective.

If you are interested in participating in one of our trials, or for more information, please visit the links below:

 

Abivertinib:

Phase 1


Phase 2


Phase 3


AC0058:

Phase 1B Study

Double-Blind, Randomized, Placebo-Controlled Study of the Safety, Pharmacokinetics and Pharmacodynamics of AC0058TA in Patients with Systemic Lupus Erythematosus (SLE)